Goldman Sachs Reaffirms Their Buy Rating on Outset Medical (OM)

Goldman Sachs analyst Amit Hazan maintained a Buy rating on Outset Medical (OMResearch Report) today and set a price target of $34.00. The company’s shares closed last Wednesday at $19.94, close to its 52-week low of $13.25.

According to, Hazan is a 4-star analyst with an average return of 6.6% and a 56.7% success rate. Hazan covers the Healthcare sector, focusing on stocks such as Bausch + Lomb Corporation, Baxter International, and Intuitive Surgical.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Outset Medical with a $33.60 average price target, which is an 80.2% upside from current levels. In a report issued on August 1, Stifel Nicolaus also reiterated a Buy rating on the stock with a $24.00 price target.

See today’s best-performing stocks on TipRanks >>

The company has a one-year high of $60.33 and a one-year low of $13.25. Currently, Outset Medical has an average volume of 850.4K.

Based on the recent corporate insider activity of 82 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of OM in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Outset Medical Inc is a medical technology company. The company has developed a machine, Tablo, which reduces the cost and complexity of dialysis.

Read More on OM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More